濮阳东方医院男科技术非常哇塞(濮阳东方医院妇科做人流评价非常好) (今日更新中)

Nurses are a critical group to get on board with taking and recommending COVID-19 vaccines.They're already the number one trusted worker by Americans, according to a new Gallup poll. And they’re seen to have the highest honesty and ethics values.“What I am advocating or stressing is that nurses need to know exactly how the mRNA vaccines work,” said Dr. Ernest Grant, President of the American Nurses Association (ANA). “You know, because they're going to be needed to help persuade the public that they need to take the vaccine as well.”Grant isn't just asking nurses to be vaccine advocates. He’s one himself. He took part in the modern vaccine trial.Grant says he believes he got the vaccine, not the placebo, because of the fatigue he felt after the second shot.He says vaccines come at a time that will not only save lives, but also keep more nurses from leaving the profession due to burnout and stress.“It’s tough to go to work to work 12 hours or 16 hour shifts a day and have, you know, maybe a death every other hour or so,” said Grant.Nurses are also losing their lives. About 400 in the U.S. have died as a result of providing care for COVID-19 patients, according to the ANA. 1197

OAKLAND, Calif. (KGTV) - Smoke from wildfires had many California residents staying indoors Sunday but the Los Angeles Chargers and Oakland Raiders game carried on at the Oakland Coliseum. The Air Quality Index for much of San Francisco and the surrounding areas was in the Environmental Protection Agency’s “red” zone, indicating the air was unhealthy to breathe.Fans and coaches donned masks while players were forced to inhale the smoke on the field. The NFL had monitored the situation but the AQI never got near 200, the level where the game would have needed to be moved, the Associated Press reported.Philip Rivers led the Chargers to a sixth straight win, defeating the Raiders 20-6.RELATED: Interactive Maps: Woolsey?and Hill Fires / Interactive Map: Camp FireThe EPA warning said people with heart or lung disease, older adults and children should avoid prolonged or heavy exertion.A smoke advisory remained in effect Sunday due to the Woolsey Fire, which was causing unhealthy air quality affecting everyone in areas directly impacted by smoke, including coastal Los Angeles County, the San Fernando Valley, the Santa Clarita Valley, the San Gabriel Valley, the San Gabriel Mountains and the Pomona-Walnut Valley.The South Coast Air Quality Management District said western winds brought unhealthful levels of smoke and ash particulate into most of the South Coast Air Basin, which includes Orange County and non-desert areas of Los Angeles, Riverside and San Bernardino counties, overnight. However, on Sunday morning, Santa Ana winds from the northeast had started to push smoke away from southern Orange and Riverside counties and were expected to continue to alleviate conditions in the northern San Fernando Valley and Los Angeles metro area through the day and into Monday.RELATED: Despite fires, San Diego's air quality remains favorableSmoke was expected to remain at unhealthy levels closest to the fire, in the western San Fernando Valley and northwest coastal Los Angeles County.``It is difficult to tell where ash or soot from a fire will go, or how winds will affect the level of dust particles in the air, so we ask everyone to be aware of their immediate environment and to take actions to safeguard their health,'' said Dr. Muntu Davis, health officer for Los Angeles County, in an earlier statement.Wildfire smoke is a mixture of small particles, gases and water vapor, and the primary health concern is the small particles, which can cause burning eyes, runny nose, scratchy throat, headaches and bronchitis, health officials said. In people with sensitive conditions, the particles can cause difficulty breathing, wheezing, coughing, fatigue, and/or chest pain.City News Service contributed to this report. 2754

OCEANSIDE, Calif. (KGTV) - North San Diego County police are searching for a documented gang member they say killed a man outside his home in 2016.Edgar Hernandez Saavedra, 29, was named as the suspect of Miguel Luis Castillo's murder on August 20, 2016, Oceanside Police said.Saavedra was arguing with Castillo outside the man's home in the 800 block of Langford St. at about 2:40 a.m. Police said the argument escalated and Saavedra shot and killed Castillo with a semi-automatic handgun.ORIGINAL REPORT: Man shot, killed in Oceanside; Suspect at largeSince then, Saavedra's whereabouts have been unknown.Police describe Saavedra as a Hispanic male, with brown hair and brown eyes, standing about 5-foot 6-inches tall, and weighing 175 pounds. He is a documented gang member and is also known as "Little Edgar" and "Smalls."Saavedra is considered armed and dangerous, police said. Anyone with information is asked to call Oceanside Police at 760-435-4027 or Crime Stoppers at 888-580-8477.  1035

On Monday morning, Pfizer announced that so far in Phase 3 trials, its COVID-19 vaccine candidate has been 90% effective in promoting protection against the virus. And while the announcement has many Americans seeing the light at the end of the tunnel, the pandemic is still far from over.Pfizer's announcement on Monday is an encouraging sign, as it means that the company is on track to file for Emergency Use Authorization for the vaccine in the coming weeks. It also keeps the U.S. on a timeline to have at least one vaccine approved and available for distribution by the end of 2021.But Monday's announcement does not mean a vaccine is imminent. Pfizer is currently mass-manufacturing its vaccine candidate in the event it does receive Emergency Use Authorization from the FDA, and hopes to have 100 million doses of the vaccine ready to ship by year's end. But even if Pfizer is able to fulfill that ambitious order by Dec. 31, it would only be able to vaccinate about one-third of everyone in the county.Once the initial vaccine order has been completed, it will need to be rationed for those who need it most — likely health care workers, essential employees and people in high-risk populations. While it is unclear who exactly will be eligible to receive the vaccine first, the Department of Health and Human Services (HHS) says the early distribution of a COVID-19 vaccine will be "constrained tightly" and will be "highly targeted" to "achieve coverage in priority populations."Eventually, the U.S. hopes to grant emergency use authorization to several vaccine candidates — many of which are currently in production on orders from the U.S. government. HHS hopes that by the middle of next year, several vaccines will be approved and widely available. But at that point, officials will run into a second major hurdle — vaccine skepticism.Skepticism about vaccines has been on the rise in recent years, fueled in part by the spread of misinformation online. In particular, baseless conspiracies linking vaccines to autism have spread on social media, eroding public confidence in medicine. In addition, polarized politics in the U.S. have led to speculation that government leaders will approve an unsafe or ineffective vaccine for political purposes.Vaccines are only effective if enough members of the public become inoculated against a virus — if a virus has nowhere to spread, it will eventually die out. But Gallup polling released in October shows that just 50% of Americans say they would receive a COVID-19 vaccine if it had been approved by the FDA and available at no cost — far below the threshold for herd immunity, according to many health experts.The Gallup polling is consistent with AP polling from earlier this year that also only found 50% willingness to take a COVID-19 vaccine.All the while, the final push for a COVID-19 vaccine will be occurring during what members of the White House coronavirus task force warn will be the most concerning and deadly period of the pandemic. The virus is currently spreading in the U.S. faster than it has at any other point during the pandemic, just as Americans are moving social gatherings indoors where the virus is more likely to spread.To be clear, health officials' efforts to develop a safe and effective COVID-19 is a momentous and historic achievement — approving a vaccine for emergency use by the end of the year would shatter all previous records for vaccine development. But while there may be light at the end of the tunnel, it may take several months — or years — to reach the end of the pandemic. 3586

One of the leading COVID-19 vaccine candidates produced virus antibodies in every patient tested in a trial conducted earlier this year, according to a report in the New England Journal of Medicine.The published results describe a successful Phase I testing for the vaccine, which is being produced by biotech company Moderna. The vaccine is currently in Phase II of testing, and Dr. Anthony Fauci said Tuesday that the vaccine would move to the third and final phase by the end of the month.According to the New England Journal of Medicine report, Phase I was conducted in 45 test subjects. Subjects were divided into three groups of 15, each of which was given different doses of the vaccine.Every subject received two shots, each administered 28 days apart.According to the New England Journal of Medicine, the vaccine "induced anti–SARS-CoV-2 immune responses in all participants."The Journal did note that half of the participants indicated they suffered from side effects that included "fatigue, chills, headache, myalgia, and pain at the injection site," most of which came after the second injection. Three of the participants who received the highest dosage of the vaccine reported at least one "severe" side effect.Fauci has said that the US is currently producing the top vaccine candidates with the hopes of distributing them when they are cleared for use by the FDA. He said Tuesday he remains "cautiously optimistic" that millions of doses of a vaccine will be available by January. 1504

来源：资阳报